USF1 inhibition has been demonstrated to ameliorate hyperlipidemia, adiposity, and atherosclerosis in mice, suggesting USF1 as a potential therapeutic target for atherosclerosis (Laurila et al. 2016). The gene discussed is USF1; the disease is hyperlipidemia.